Lan Yu-Wen, Hsieh Jui-Wen
Department of Ophthalmology, MacKay Memorial Hospital, No. 92, Sec. 2, Chung Shan N. Rd., Taipei, 104, Taiwan.
Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
Int Ophthalmol. 2018 Dec;38(6):2639-2648. doi: 10.1007/s10792-017-0740-y. Epub 2017 Oct 24.
To report two cases of ciliochoroidal effusion after the usage of topiramate.
Two middle-aged women experienced sudden onset of acute glaucoma and acquired myopia after taking topiramate. Ultrasound biomicroscopy demonstrated bilateral ciliochoroidal effusion and angle closure. The A-scan ultrasonography revealed shallow anterior chamber and thick lens. After the treatment and drug withdrawal, intraocular pressure, refractive status and angle anatomy returned to normal and there was resolution of ciliochoroidal effusion. During the clinical course, the anterior chamber depth (ACD) increased from 2.02 to 3.30 mm (1.28 mm of changes) OD and from 1.94 to 3.36 mm (1.42 mm of changes) OS. The lens thickness (LT) became thinner from 4.53 to 4.31 mm (0.22 mm of changes) OD and from 4.59 to 4.30 mm (0.29 mm of changes) OS in the first case. In the second case, the ACD increased from 2.33 to 3.07 mm (0.74 mm of changes) OD and from 2.30 to 3.05 mm (0.75 mm of changes) OS. The LT became thinner from 4.42 to 4.27 mm (0.15 mm of changes) OD and from 4.38 to 4.26 mm (0.12 mm of changes) OS. The forward displacement of the lens-iris diaphragm contributed more to the shallowness of the anterior chamber than the thickening of the lens itself (only accounting for 20%).
Topiramate-induced bilateral acute angle closure glaucoma and myopic shift was due to ciliochoroidal effusion which resulted in thicker lens and shallow anterior chamber. The later was mainly due to anterior displacement of the lens-iris diaphragm.
报告两例使用托吡酯后发生睫状体脉络膜积液的病例。
两名中年女性在服用托吡酯后突然出现急性青光眼和获得性近视。超声生物显微镜检查显示双侧睫状体脉络膜积液和房角关闭。A 超检查显示前房浅、晶状体厚。治疗及停药后,眼压、屈光状态和房角结构恢复正常,睫状体脉络膜积液消退。在临床过程中,第一例患者右眼的前房深度(ACD)从 2.02 毫米增加到 3.30 毫米(变化 1.28 毫米),左眼从 1.94 毫米增加到 3.36 毫米(变化 1.42 毫米)。第一例患者右眼的晶状体厚度(LT)从 4.53 毫米变薄至 4.31 毫米(变化 0.22 毫米),左眼从 4.59 毫米变薄至 4.30 毫米(变化 0.29 毫米)。第二例患者右眼的 ACD 从 2.33 毫米增加到 3.07 毫米(变化 0.74 毫米),左眼从 2.30 毫米增加到 3.05 毫米(变化 0.75 毫米)。右眼的 LT 从 4.42 毫米变薄至 4.27 毫米(变化 0.15 毫米),左眼从 4.38 毫米变薄至 4.26 毫米(变化 0.12 毫米)。晶状体 - 虹膜隔的向前移位对前房变浅的影响比晶状体本身增厚更大(仅占 20%)。
托吡酯引起的双侧急性闭角型青光眼和近视性移位是由于睫状体脉络膜积液,导致晶状体增厚和前房变浅。后者主要是由于晶状体 - 虹膜隔向前移位。